Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 4 min ago
Peer-reviewedCC BY-NC-ND 4.0Movement Disorders

Alkaline Phosphatases: A Potential Cause of Variability in Therapeutic Response to Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion?

  • Manon Auffret
  • Marc Vérin
Open at sourcePDFDOICite

Related

  1. Continuous Subcutaneous Foslevodopa/Foscarbidopa Improves Nonmotor Symptoms and Fluctuations in Parkinson's Disease
    Rosa De Micco, Oriana Ciaramaglia, Mattia Siciliano +4
    European Journal of NeurologyPeer-reviewedCC BY-NC 4.0Full textNeurologyPMCEurope PMC
  2. Ekbom Spectrum Psychosis Associated with 24-hour Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion in Parkinson’s Disease
    Mario Meloni, Fabrizio De Ascaniis, Gianni Orofino +4
    Clinical Psychopharmacology and NeurosciencePeer-reviewedCC BY-NC 4.0Full textNeurologyPMC
  3. Homocysteine as a Key Biomarker of Metabolic Stress During Foslevodopa/Foscarbidopa Infusion Therapy
    Fabienne Ory Magne, Solène Frismand, Sophie Drapier +1
    Movement DisordersPeer-reviewedLicence not statedFull textNeurologyHAL
  4. Pneumomediastinum and Subcutaneous Emphysema After Rapid Mediastinal Mass Regression
    Fahad Alsayed, Ailish Coblentz, Oussama Abla
    eJHaemPeer-reviewedCC BYFull textEndocrinology & metabolismDOAJ
  5. Subcutaneous translocation of residual thyroid tissue: a novel functional-preserving technique for partial thyroidectomy with 1-year follow-up retrospective case series
    Gland SurgeryPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@article{auffret2026alkaline,
  title = {{Alkaline Phosphatases: A Potential Cause of Variability in Therapeutic Response to Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion?}},
  author = {Manon Auffret and Marc Vérin},
  journal = {Movement Disorders},
  year = {2026},
  month = jun,
  doi = {10.1002/mds.70414},
  url = {https://hal.science/hal-05674154v1},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Alkaline Phosphatases: A Potential Cause of Variability in Therapeutic Response to Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion?
AU  - Manon Auffret
AU  - Marc Vérin
PY  - 2026
DA  - 2026/06/18
JO  - Movement Disorders
DO  - 10.1002/mds.70414
UR  - https://hal.science/hal-05674154v1
SN  - 0885-3185
SN  - 1531-8257
ER  -